ID

43964

Descrizione

NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection

Keywords

versioni (2)
  1. 30/07/17 30/07/17 -
  2. 20/09/21 20/09/21 -
Titolare del copyright

GlaxoSmithKline

Caricato su

20 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons SERIOUS ADVERSE EVENTS NCT00079911

Inglese

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons SERIOUS ADVERSE EVENTS NCT00079911

1 moduli  
Study administration
Descrizione

Study administration

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
Centre Number
Descrizione

Centre Number

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Randomisation Number
Descrizione

Randomisation Number

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
SERIOUS ADVERSE EVENTS
Descrizione

SERIOUS ADVERSE EVENTS

Did the subject experience a serious adverse event during the study?
Descrizione

If Yes, record details below.

Tipo di dati

text

Alias
UMLS CUI [1]
C1519255
If fatal, was a post-mortem/autopsy performed
Descrizione

If Yes, summarise findings in Section 11 Narrative Remarks of this SAE form.

Tipo di dati

text

Alias
UMLS CUI [1]
C4274690
Section 1 SERIOUS ADVERSE EVENTS
Descrizione

Section 1 SERIOUS ADVERSE EVENTS

Event
Descrizione

Diagnosis Only (if known) Otherwise Sign/Symptom e.g., Headache

Tipo di dati

text

Alias
UMLS CUI [1]
C0877248
Start Date
Descrizione

adverse event start date

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1]
C2697888
DD/MMM/YY
Outcome
Descrizione

Outcome

Tipo di dati

integer

Alias
UMLS CUI [1]
C1705586
End Date
Descrizione

If fatal, record date of death.

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1]
C2697886
DD/MMM/YY
Maximum Intensity
Descrizione

Maximum Intensity

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1710056
UMLS CUI [1,2]
C1518404
Action taken with investigational product(s) as a result of the SAE
Descrizione

Action taken with investigational product

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1704758
UMLS CUI [1,2]
C1519255
Did the subject withdraw from study as a result of this SAE?
Descrizione

Withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1710677
UMLS CUI [1,2]
C1519255
Is there a reasonable possibility that the SAE may have been caused by the investigational product?
Descrizione

Relationship to investigational products

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1519255
Section 2 Seriousness
Descrizione

Section 2 Seriousness

[A] Results in death
Descrizione

patient dead

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011065
[B] Is life-threatening
Descrizione

life threatening

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826244
[C] Requires hospitalisation or prolongation of existing hospitalisation
Descrizione

hospitalisation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019993
[D] Results in disability/incapacity
Descrizione

disability

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0231170
[E] Congenital anomaly/birth defect
Descrizione

congenital anomaly

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826727
[F] Other, specify
Descrizione

(see definition of SAE)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1710056
[F] Other, specify
Descrizione

(see definition of SAE)

Tipo di dati

text

Alias
UMLS CUI [1]
C1710056
Section 3 Demography Data
Descrizione

Section 3 Demography Data

Date of birth
Descrizione

Date of birth

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1]
C0421451
DD/MMM/YY
Sex
Descrizione

Sex

Tipo di dati

integer

Alias
UMLS CUI [1]
C0079399
Weight
Descrizione

Weight

Tipo di dati

float

Alias
UMLS CUI [1]
C0005910
Section 4 If lnvestigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further lnvestigational Product(s) were Administered?
Descrizione

Section 4 If lnvestigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further lnvestigational Product(s) were Administered?

If deliberate or inadvertant administration of further dose(s) of investigational product(s) to the subject occurred, did the reported adverse event recur?
Descrizione

inadvertant administration

Tipo di dati

text

Alias
UMLS CUI [1]
C1536055
If lnvestigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further lnvestigational Product(s) were Administered?
Descrizione

ae after readministration of drug

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0376495
UMLS CUI [1,2]
C0877248
Section 5 Possible Causes of SAE Other Than lnvestigational Product(s)
Descrizione

Section 5 Possible Causes of SAE Other Than lnvestigational Product(s)

Disease under study
Descrizione

Disease under study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0012634
Medical condition(s)
Descrizione

(record in Section 6)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0012634
Lack of efficacy
Descrizione

Lack of efficacy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0235828
Withdrawal of investigational products
Descrizione

Withdrawal of investigational product

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0013227
Concomitant medication
Descrizione

(record in Section 8)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
Activity related to study participation (e.g. procedures)
Descrizione

Activity related to study participation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
Other, specify
Descrizione

other cause sae

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0085978
Other, specify
Descrizione

other cause sae

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0085978
Section 6 RELEVANT Medical Conditions
Descrizione

Section 6 RELEVANT Medical Conditions

Specify any RELEVANT past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE
Descrizione

SAE causation

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0085978
Date of Onset
Descrizione

Onset Date

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C0574845
UMLS CUI [1,2]
C0348080
DD/MMM/YY
Condition Present at Time of the SAE?
Descrizione

present at sae

Tipo di dati

text

Alias
UMLS CUI [1,1]
C3827351
UMLS CUI [1,2]
C1519255
If No, Date of Last Occurrence
Descrizione

Date of Last Occurrence

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C2745955
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C0011008
UMLS CUI [1,4]
C1519255
DD/MMM/YY
Section 7 Other RELEVANT Risk Factors
Descrizione

Section 7 Other RELEVANT Risk Factors

Other RELEVANT Risk Factors
Descrizione

risk factor

Tipo di dati

text

Alias
UMLS CUI [1]
C0035648
Section 8 RELEVANT Concomitant Medications
Descrizione

Section 8 RELEVANT Concomitant Medications

Drug Name
Descrizione

(Trade Name preferred)

Tipo di dati

text

Alias
UMLS CUI [1]
C0013227
Dose
Descrizione

Dose

Tipo di dati

text

Alias
UMLS CUI [1]
C3174092
Unit
Descrizione

Unit

Tipo di dati

text

Alias
UMLS CUI [1]
C2348328
Frequency
Descrizione

Frequency

Tipo di dati

text

Alias
UMLS CUI [1]
C3476109
Route
Descrizione

administration route

Tipo di dati

text

Alias
UMLS CUI [1]
C0013153
Taken Prior to Study?
Descrizione

taken prior to study

Tipo di dati

text

Alias
UMLS CUI [1]
C2826667
Start Date
Descrizione

concomitant medication start date

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1]
C2826734
DD/MMM/YY
Stop Date
Descrizione

concomitant medication end date

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1]
C2826744
DD/MMM/YY
Ongoing Medication?
Descrizione

Ongoing Medication

Tipo di dati

text

Alias
UMLS CUI [1]
C2826666
Reason for Medication
Descrizione

Reason for Medication

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013227
Section 9 Details of lnvestigational Product(s)
Descrizione

Section 9 Details of lnvestigational Product(s)

Double-Blind Therapy Start Date
Descrizione

Double-Blind Therapy Start Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0013072
UMLS CUI [1,2]
C0808070
Double-Blind Therapy Stop Date
Descrizione

Double-Blind Therapy End Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0013072
UMLS CUI [1,2]
C0806020
Open-Label Treatment Start Date
Descrizione

Open-Label Treatment Start Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C3640652
UMLS CUI [1,2]
C0808070
Open-Label Treatment Stop Date
Descrizione

Open-Label Treatment End Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C3640652
UMLS CUI [1,2]
C0806020
Section 10 Details of RELEVANT Assessments
Descrizione

Section 10 Details of RELEVANT Assessments

Details of RELEVANT Assessments
Descrizione

assessment adverse event

Tipo di dati

text

Alias
UMLS CUI [1]
C1161049
Section 11 Narrative Remarks
Descrizione

Section 11 Narrative Remarks

Provide a brief narrative description of the SAE and details of treatment given
Descrizione

SAE description

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0678257
Ritorna all'inizio della pagina

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons SERIOUS ADVERSE EVENTS NCT00079911

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Randomisation Number
Item
Randomisation Number
text
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Item Group
SERIOUS ADVERSE EVENTS
Item
Did the subject experience a serious adverse event during the study?
text
C1519255 (UMLS CUI [1])
adverse event
Code List
Did the subject experience a serious adverse event during the study?
CL Item
Yes (Y)
CL Item
No (N)
Item
If fatal, was a post-mortem/autopsy performed
text
C4274690 (UMLS CUI [1])
adverse event
Code List
If fatal, was a post-mortem/autopsy performed
CL Item
Yes (Y)
CL Item
No (N)
Item Group
Section 1 SERIOUS ADVERSE EVENTS
Event
Item
Event
text
C0877248 (UMLS CUI [1])
adverse event start date
Item
Start Date
date
C2697888 (UMLS CUI [1])
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Recovered / Resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae / Resolved with sequelae (4)
CL Item
Fatal (5)
adverse event end date
Item
End Date
date
C2697886 (UMLS CUI [1])
Item
Maximum Intensity
text
C1710056 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Maximum Intensity
Code List
Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (X)
Item
Action taken with investigational product(s) as a result of the SAE
text
C1704758 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Action taken with investigational product
Code List
Action taken with investigational product(s) as a result of the SAE
CL Item
Investigational Product(s) withdrawn (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (X)
Item
Did the subject withdraw from study as a result of this SAE?
text
C1710677 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
adverse event
Code List
Did the subject withdraw from study as a result of this SAE?
CL Item
Yes (Y)
CL Item
No (N)
Item
Is there a reasonable possibility that the SAE may have been caused by the investigational product?
text
C0085978 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
adverse event
Code List
Is there a reasonable possibility that the SAE may have been caused by the investigational product?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
Section 2 Seriousness
patient dead
Item
[A] Results in death
boolean
C0011065 (UMLS CUI [1])
life threatening
Item
[B] Is life-threatening
boolean
C2826244 (UMLS CUI [1])
hospitalisation
Item
[C] Requires hospitalisation or prolongation of existing hospitalisation
boolean
C0019993 (UMLS CUI [1])
disability
Item
[D] Results in disability/incapacity
boolean
C0231170 (UMLS CUI [1])
congenital anomaly
Item
[E] Congenital anomaly/birth defect
boolean
C2826727 (UMLS CUI [1])
Other seriousness
Item
[F] Other, specify
boolean
C1710056 (UMLS CUI [1])
Other seriousness
Item
[F] Other, specify
text
C1710056 (UMLS CUI [1])
Item Group
Section 3 Demography Data
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Sex
integer
C0079399 (UMLS CUI [1])
Sex
Code List
Sex
CL Item
Male (1)
CL Item
Female (2)
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Item Group
Section 4 If lnvestigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further lnvestigational Product(s) were Administered?
inadvertant administration
Item
If deliberate or inadvertant administration of further dose(s) of investigational product(s) to the subject occurred, did the reported adverse event recur?
text
C1536055 (UMLS CUI [1])
Item
If lnvestigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further lnvestigational Product(s) were Administered?
integer
C0376495 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
ae after readministration of drug
Code List
If lnvestigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further lnvestigational Product(s) were Administered?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Item Group
Section 5 Possible Causes of SAE Other Than lnvestigational Product(s)
Disease under study
Item
Disease under study
boolean
C0012634 (UMLS CUI [1])
Medical condition
Item
Medical condition(s)
boolean
C0012634 (UMLS CUI [1])
Lack of efficacy
Item
Lack of efficacy
boolean
C0235828 (UMLS CUI [1])
Withdrawal of investigational product
Item
Withdrawal of investigational products
boolean
C2349954 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Concomitant medication
Item
Concomitant medication
boolean
C2347852 (UMLS CUI [1])
Activity related to study participation
Item
Activity related to study participation (e.g. procedures)
boolean
C2348568 (UMLS CUI [1])
other cause sae
Item
Other, specify
boolean
C1519255 (UMLS CUI [1,1])
C0085978 (UMLS CUI [1,2])
other cause sae
Item
Other, specify
text
C1519255 (UMLS CUI [1,1])
C0085978 (UMLS CUI [1,2])
Item Group
Section 6 RELEVANT Medical Conditions
SAE causation
Item
Specify any RELEVANT past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE
text
C1519255 (UMLS CUI [1,1])
C0085978 (UMLS CUI [1,2])
Onset Date
Item
Date of Onset
date
C0574845 (UMLS CUI [1,1])
C0348080 (UMLS CUI [1,2])
Item
Condition Present at Time of the SAE?
text
C3827351 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
adverse event
Code List
Condition Present at Time of the SAE?
CL Item
Yes (Y)
CL Item
No (N)
Date of Last Occurrence
Item
If No, Date of Last Occurrence
date
C2745955 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,4])
Item Group
Section 7 Other RELEVANT Risk Factors
risk factor
Item
Other RELEVANT Risk Factors
text
C0035648 (UMLS CUI [1])
Item Group
Section 8 RELEVANT Concomitant Medications
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Dose
Item
Dose
text
C3174092 (UMLS CUI [1])
Unit
Item
Unit
text
C2348328 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
administration route
Item
Route
text
C0013153 (UMLS CUI [1])
Item
Taken Prior to Study?
text
C2826667 (UMLS CUI [1])
adverse event
Code List
Taken Prior to Study?
CL Item
Yes (Y)
CL Item
No (N)
concomitant medication start date
Item
Start Date
date
C2826734 (UMLS CUI [1])
concomitant medication end date
Item
Stop Date
date
C2826744 (UMLS CUI [1])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1])
adverse event
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)
Reason for Medication
Item
Reason for Medication
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Item Group
Section 9 Details of lnvestigational Product(s)
Double-Blind Therapy Start Date
Item
Double-Blind Therapy Start Date
date
C0013072 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Double-Blind Therapy End Date
Item
Double-Blind Therapy Stop Date
date
C0013072 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Open-Label Treatment Start Date
Item
Open-Label Treatment Start Date
date
C3640652 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Open-Label Treatment End Date
Item
Open-Label Treatment Stop Date
date
C3640652 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Section 10 Details of RELEVANT Assessments
assessment adverse event
Item
Details of RELEVANT Assessments
text
C1161049 (UMLS CUI [1])
Item Group
Section 11 Narrative Remarks
SAE description
Item
Provide a brief narrative description of the SAE and details of treatment given
text
C1519255 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial